An Israeli company called Cannasure has achieved success in a possible cannabis treatment.
The company, which focuses on medical cannabis research, announced the successful completion of the first stage of research meant to examine the effects of the plant on skin-related diseases.
Canassure and a Swedish company named Lipidor have been conducting the research that examined the possibility of using cannabinoids together with one the Lipidor’s experimental skin products.
The idea is to utilize cannabinoids in the form of aerosol that can be applied on the patient’s skin.
Dr. Hadie Ounallah-Saad, vice president of Canassure’s R&D division has said that “there is evidence showing that medical cannabis may alleviate skin problems.”
The cannabinoids however need to be properly absorbed by the skin and Lipidor has the necessary technology that can do just that.
Ido Nehushtan, Canassure’s CEO, said that “the company is exploring various opportunities to develop and commercialize a wide range of new cannabis-based medical products.”
